All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Thu 1972-06-01? to Thu 2024-10-17 |
YTD
Return |
TR
Price |
||||
|---|---|---|---|---|---|---|
| LLY × |
+58.10%
2024-10-17 |
1014.63 TR
2024-10-17 |
||||
| Eli Lilly and Company NYSE Common Stock | ||||||
| Thu 1972-06-01? to Thu 2024-10-17 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| LLY × |
+101,362.55%
+14.13%/yr |
+12.55%/yr
(R2=0.921) |
||||
| Eli Lilly and Company NYSE Common Stock | ||||||
| Thu 1972-06-01? to Thu 2024-10-17 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| LLY × |
$10,000.00
1972-06-01 |
$10,146,255.12
2024-10-17 |
||||
| Eli Lilly and Company NYSE Common Stock | ||||||
| Year | LLY |
|---|---|
| 2024 (YTD) | +58.10% |
| 2023 | +60.91% |
| 2022 | +34.24% |
| 2021 | +66.07% |
| 2020 | +31.03% |
| 2019 | +16.14% |
| 2018 | +40.45% |
| 2017 | +17.83% |
| 2016 | −10.37% |
| 2015 | +25.39% |
| 2014 | +39.75% |
| 2013 | +7.29% |
| 2012 | +24.26% |
| 2011 | +25.18% |
| 2010 | +3.66% |
| 2009 | −6.24% |
| 2008 | −21.33% |
| 2007 | +5.69% |
| 2006 | −5.18% |
| 2005 | +2.53% |
| 2004 | −17.54% |
| 2003 | +13.14% |
| 2002 | −17.57% |
| 2001 | −14.42% |
| 2000 | +41.89% |
| 1999 | −24.24% |
| 1998 | +29.12% |
| 1997 | +93.51% |
| 1996 | +32.65% |
| 1995 | +77.33% |
| 1994 | +15.63% |
| 1993 | +2.45% |
| 1992 | −24.88% |
| 1991 | +16.99% |
| 1990 | +9.50% |
| 1989 | +64.13% |
| 1988 | +12.82% |
| 1987 | +7.48% |
| 1986 | +36.80% |
| 1985 | +75.75% |
| 1984 | +19.75% |
| 1983 | +5.12% |
| 1982 | +7.55% |
| 1981 | −8.33% |
| 1980 | +11.19% |
| 1979 | +29.44% |
| 1978 | +30.77% |
| 1977 | −17.39% |
| 1976 | −5.53% |
| 1975 | −22.78% |
| 1974 | −6.82% |
| 1973 | −6.16% |
| 1972 | +23.56% |
| Thu 1972-06-01? to Thu 2024-10-17 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| LLY × | −4.47% |
−68.27%
2009-03-05 |
||||
| Eli Lilly and Company NYSE Common Stock | ||||||